News | April 08, 2009

Aurora Wins Frost & Sullivan Award for Breast MRI Market Penetration

April 8, 2009 - Frost & Sullivan selected Aurora Imaging Technology for the 2009 Vertical Market Penetration Leadership Award in the North American Magnetic Resonance Imaging (MRI) Scanners Market in recognition of the company’s strong growth within the Breast MRI market due to its robust offering of imaging, IT and financial assistance solutions.

“The breast MRI market gained momentum in 2008 with several emerging studies highlighting the effectiveness and clinical excellence of the modality,” stated Travis Chong, industry analyst – Healthcare Sector, Frost & Sullivan. “As end-users sought a champion within this vertical market, Aurora Imaging emerged as the company wielding both functional technology and company excellence. On the technology side, Aurora introduced a new set of Breast MRI solutions that supplements the market’s only FDA-approved dedicated breast MRI scanner, marking the company’s clear understanding of the unique needs within the breast MRI market. Even more impressive, however, was the company’s introduction of capital financial and continued medical education activities that were directly tailored to assist operations,” added Chong.

“Aurora Imaging understands that being profitable in a vertical market such as breast MRI remains an ongoing challenge for imaging centers, especially given today’s current financial and economic turmoil. Imaging centers are increasingly struggling with rising operational costs and more stringent accreditation protocols, yet most are being presented “solutions” by sales-oriented manufacturers with generic messages that fail to address individual customers’ unique needs. Without the integrated support of imaging and IT, these “one-size-fits-all” solutions fail to resolve workflow and workforce deficiencies, leading to unrealized (and thereby lost) potential revenue channels and profitability.”
Chong continued, “Aurora breaks from the norm by defining success not by the initial sales the company achieves, but rather by its success in offering integrated imaging and IT services throughout a customer’s entire ownership experience. Such services are offered under two principles: 1) Increase awareness and accessibility to leading technology for breast MRI imaging through its Aurora Breast MRI Society (www.aurorabreastmri.com) and AuroraCAPITAL™ services, respectively, and 2) Equip the facility with the necessary imaging and IT tools to drive product utilization and realize additional channels to revenue. Indeed, on the technology side, the company introduced in November 2008 two innovations (AuroraSPECTROSCOPY™ and AuroraEDGE™) that bring additional clinical value to the Aurora® Dedicated Breast MRI scanner. AuroraSPECTROSCOPY™ is the company’s first breast MRI spectroscopy package that enables end-users to perform supplementary in-vivo breast MRI spectroscopy and MR spectroscopic imaging. The next-generation AuroraEDGE™ pulse sequence and image acquisition system goes even further with improved image resolution and the virtual elimination of motion artifacts. Additionally, AuroraEDGE offers isotropic 0.7mm resolution in all 3 planes with a total patient scan time of 18 minutes.”
“More impressive, however, is the solutions that have come forth from Aurora that assist its customers in entering and tracking the breast MRI market as well as in making adjustments to meet changes in clinical and business needs over time. The company announced in June 2008 the formation of AuroraCAPITAL, the company’s exclusive financing group created to assist customers with financing Aurora technologies. By leveraging its capital assistance prowess and flexibility in financial solutions tailored to individual customer needs, the company has effectively minimized major acquisition obstacles present in today’s limited capital world. As such, the company displays a rarified level of personal assistance that hallmarks the company’s continuous efforts to understand and improve the business model of each client.”
“In addition, the Aurora Breast MRI Society (established in 2006) launched its first issue of The Journal of Breast MRI in July 2008. Designed to relay emerging clinical and regulatory information on breast MRI, the journal serves as an invaluable knowledge resource that readers can leverage to track market dynamics and formulate growth-focused actionables based on best practices detailed within the journal. As the breast MRI market divides into further subsegments (i.e. MR spectroscopy, MR-guided biopsy, etc.), the journal is anticipated to function as a technology and best practice advisor to readers looking to gain a better understanding of the acute dynamics within each market segment.”
Chong concluded, “in short, Aurora has effectively differentiated itself in the industry with its complete set of technology, financial, and CME applications for breast MRI. Accordingly, the company has managed to achieve significant growth in 2007 and 2008. With promising technology and outstanding customer services, Aurora has positioned itself to be the leading technology provider in breast MRI for years to come. Based on these factors, Frost & Sullivan is proud to present Aurora Imaging Technology with the 2009 Vertical Market Penetration Leadership Award in the North American Magnetic Resonance Imaging Scanners Market.”

For more information: www.auroramri.com

Related Content

Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
Rapid Breast MRI, breast cancer screening, David Strahle, RMI, Breast Cancer Research and Treatment study
News | MRI Breast | February 10, 2017
February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives
breast MRI, new AB-MR exam protocol, Via Radiology, cancer detection, dense breasts, women's health
News | MRI Breast | February 07, 2017
A newly developed breast magnetic resonance imaging (MRI) exam protocol, the first of its kind being offered in the...
News | MRI Breast | June 27, 2016
A new phase 1 clinical trial from Brigham and Women's Hospital published in Radiology on June 22 evaluated the...
breast MRI, ER-positive breast cancer detection, Case Western Reserve study

Differences in dynamic textural patterns are apparent between a patient with a low recurrence score, left, and a patient with a high recurrence score, right. Image courtesy of Nature Scientific Reports

News | MRI Breast | February 19, 2016
February 19, 2016 — A new way to analyze magnet...

Molecular imaging of the GRPR biomarker on mice xenografted with PC3 and H441 cells by T1-weighted spin echo MR imaging and NIR imaging.

News | Magnetic Resonance Imaging (MRI) | December 29, 2015
December 29, 2015 — A method to better trace changes in cancers and treatment of the prostate and lung without the li
Overlay Init